Hoh Brian L, Carter Bob S, Ogilvy Christopher S
Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Neurosurgery. 2002 Jun;50(6):1207-11; discussion 1211-2. doi: 10.1097/00006123-200206000-00006.
Hypertensive hypervolemic therapy for vasospasm is widely practiced. It is not clear, however, whether the use of hypertension and hypervolemia as a treatment for vasospasm risks hemorrhage from an unsecured, unruptured aneurysm.
From 1991 to 2000, the neurovascular unit at the Massachusetts General Hospital treated 1908 aneurysms, of which 966 were ruptured. Forty patients with ruptured aneurysms had unsecured, unruptured aneurysms and underwent hypertensive hypervolemic therapy for vasospasm. Hypertension was induced by intravenously administered phenylephrine, norepinephrine, and/or dopamine, and hypervolemia was achieved by intravenously administered crystalloid and colloid solutions. The 24-hour mean arterial systolic blood pressure (SBP) and the 24-hour mean central venous pressure were calculated on the basis of hourly measurements during hypertensive hypervolemic treatment.
The 40 study patients harbored 124 aneurysms, of which 51 aneurysms were treated (clipping, 37; coiling, 14) by the time hypertensive hypervolemic therapy began, leaving 73 unsecured aneurysms at risk. The mean size of the unsecured aneurysms was 4.45 mm. Nineteen patients were treated with mild hypertension (SBP, 140-180 mmHg), 12 patients were treated with moderate hypertension (SBP, 180-200 mmHg), and 9 patients were treated with severe hypertension (SBP, >200 mmHg). The 24-hour mean SBP readings were 166.81 +/- 8.19, 187.57 +/- 5.79, and 204.01 +/- 3.75 mmHg for the mild, moderate, and severe hypertension groups, respectively. The mean central venous pressure was 10.43 +/- 3.89 mmHg. The mean course of hypertensive hypervolemic therapy was 7.25 days, and therapy began on mean post-subarachnoid hemorrhage Day 6.73. Twenty-eight aneurysms were eventually treated in later procedures (clipping, 25; coiling, 3). The mean interval to treatment was 6.93 months. In a treatment and follow-up period of 121.75 aneurysm-years of risk, there was no instance of hemorrhage.
Hypertension and hypervolemia do not seem to increase the risk of hemorrhage from unsecured, unruptured aneurysms in the acute setting or in their short-term natural history.
高血压高血容量疗法治疗血管痉挛应用广泛。然而,目前尚不清楚将高血压和高血容量作为血管痉挛的治疗方法是否会增加未破裂、未处理动脉瘤出血的风险。
1991年至2000年,马萨诸塞州总医院神经血管科治疗了1908例动脉瘤,其中966例为破裂动脉瘤。40例破裂动脉瘤患者存在未破裂、未处理的动脉瘤,并接受高血压高血容量疗法治疗血管痉挛。通过静脉注射去氧肾上腺素、去甲肾上腺素和/或多巴胺诱导高血压,通过静脉注射晶体液和胶体液实现高血容量。在高血压高血容量治疗期间,根据每小时测量值计算24小时平均动脉收缩压(SBP)和24小时平均中心静脉压。
40例研究患者共存在124个动脉瘤,在开始高血压高血容量疗法时,其中51个动脉瘤已接受治疗(夹闭37个,栓塞14个),剩余73个未处理的动脉瘤有出血风险。未处理动脉瘤的平均大小为4.45mm。19例患者接受轻度高血压治疗(SBP为140 - 180mmHg),12例患者接受中度高血压治疗(SBP为180 - 200mmHg),9例患者接受重度高血压治疗(SBP > 200mmHg)。轻度、中度和重度高血压组的24小时平均SBP读数分别为166.81±8.19、187.57±5.79和204.01±3.75mmHg。平均中心静脉压为10.43±3.89mmHg。高血压高血容量疗法的平均疗程为7.25天,治疗于蛛网膜下腔出血后平均第6.73天开始。28个动脉瘤最终在后续手术中接受治疗(夹闭25个,栓塞3个)。平均治疗间隔为6.93个月。在121.75个动脉瘤 - 年的治疗和随访风险期内,未发生出血事件。
在急性情况下或短期自然病程中,高血压和高血容量似乎不会增加未破裂、未处理动脉瘤出血的风险。